470 related articles for article (PubMed ID: 30280836)
1. Chitosan-based Nanoparticles in Mucosal Vaccine Delivery.
Mehrabi M; Montazeri H; Mohamadpour Dounighi N; Rashti A; Vakili-Ghartavol R
Arch Razi Inst; 2018 Sep; 73(3):165-176. PubMed ID: 30280836
[TBL] [Abstract][Full Text] [Related]
2. A strong adjuvant based on glycol-chitosan-coated lipid-polymer hybrid nanoparticles potentiates mucosal immune responses against the recombinant Chlamydia trachomatis fusion antigen CTH522.
Rose F; Wern JE; Gavins F; Andersen P; Follmann F; Foged C
J Control Release; 2018 Feb; 271():88-97. PubMed ID: 29217176
[TBL] [Abstract][Full Text] [Related]
3. Mono-N-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery.
Sayin B; Somavarapu S; Li XW; Thanou M; Sesardic D; Alpar HO; Senel S
Int J Pharm; 2008 Nov; 363(1-2):139-48. PubMed ID: 18662762
[TBL] [Abstract][Full Text] [Related]
4. Development of a novel adjuvanted nasal vaccine: C48/80 associated with chitosan nanoparticles as a path to enhance mucosal immunity.
Bento D; Staats HF; Gonçalves T; Borges O
Eur J Pharm Biopharm; 2015 Jun; 93():149-64. PubMed ID: 25818119
[TBL] [Abstract][Full Text] [Related]
5. Advances and Potential Applications of Chitosan Nanoparticles as a Delivery Carrier for the Mucosal Immunity of Vaccine.
Li D; Fu D; Kang H; Rong G; Jin Z; Wang X; Zhao K
Curr Drug Deliv; 2017; 14(1):27-35. PubMed ID: 27494157
[TBL] [Abstract][Full Text] [Related]
6. The Application of Mucoadhesive Chitosan Nanoparticles in Nasal Drug Delivery.
Shim S; Yoo HS
Mar Drugs; 2020 Nov; 18(12):. PubMed ID: 33260406
[TBL] [Abstract][Full Text] [Related]
7. Development and characterization of surface modified PLGA nanoparticles for nasal vaccine delivery: effect of mucoadhesive coating on antigen uptake and immune adjuvant activity.
Pawar D; Mangal S; Goswami R; Jaganathan KS
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):550-9. PubMed ID: 23831265
[TBL] [Abstract][Full Text] [Related]
8. Development and characterization of chitosan coated poly-(ɛ-caprolactone) nanoparticulate system for effective immunization against influenza.
Gupta NK; Tomar P; Sharma V; Dixit VK
Vaccine; 2011 Nov; 29(48):9026-37. PubMed ID: 21939718
[TBL] [Abstract][Full Text] [Related]
9. Induction of mucosal immune responses and protection of cattle against direct-contact challenge by intranasal delivery with foot-and-mouth disease virus antigen mediated by nanoparticles.
Pan L; Zhang Z; Lv J; Zhou P; Hu W; Fang Y; Chen H; Liu X; Shao J; Zhao F; Ding Y; Lin T; Chang H; Zhang J; Zhang Y; Wang Y
Int J Nanomedicine; 2014; 9():5603-18. PubMed ID: 25506214
[TBL] [Abstract][Full Text] [Related]
10. Mucosal Immunity and Protective Efficacy of Intranasal Inactivated Influenza Vaccine Is Improved by Chitosan Nanoparticle Delivery in Pigs.
Dhakal S; Renu S; Ghimire S; Shaan Lakshmanappa Y; Hogshead BT; Feliciano-Ruiz N; Lu F; HogenEsch H; Krakowka S; Lee CW; Renukaradhya GJ
Front Immunol; 2018; 9():934. PubMed ID: 29770135
[TBL] [Abstract][Full Text] [Related]
11. Adjuvants and delivery systems based on polymeric nanoparticles for mucosal vaccines.
Jin Z; Gao S; Cui X; Sun D; Zhao K
Int J Pharm; 2019 Dec; 572():118731. PubMed ID: 31669213
[TBL] [Abstract][Full Text] [Related]
12. Modified chitosan-based nanoadjuvants enhance immunogenicity of protein antigens after mucosal vaccination.
Sinani G; Sessevmez M; Gök MK; Özgümüş S; Alpar HO; Cevher E
Int J Pharm; 2019 Oct; 569():118592. PubMed ID: 31386881
[TBL] [Abstract][Full Text] [Related]
13. Mucoadhesive glycol chitosan nanoparticles for intranasal delivery of hepatitis B vaccine: enhancement of mucosal and systemic immune response.
Pawar D; Jaganathan KS
Drug Deliv; 2016; 23(1):185-94. PubMed ID: 24825494
[TBL] [Abstract][Full Text] [Related]
14. Mucosal immunization with recombinant influenza hemagglutinin protein and poly gamma-glutamate/chitosan nanoparticles induces protection against highly pathogenic influenza A virus.
Moon HJ; Lee JS; Talactac MR; Chowdhury MY; Kim JH; Park ME; Choi YK; Sung MH; Kim CJ
Vet Microbiol; 2012 Dec; 160(3-4):277-89. PubMed ID: 22763171
[TBL] [Abstract][Full Text] [Related]
15. Pharmaceutical and immunological evaluation of mucoadhesive nanoparticles based delivery system(s) administered intranasally.
Mangal S; Pawar D; Garg NK; Jain AK; Vyas SP; Rao DS; Jaganathan KS
Vaccine; 2011 Jul; 29(31):4953-62. PubMed ID: 21575664
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous Intramuscular And Intranasal Administration Of Chitosan Nanoparticles-Adjuvanted
Li Y; Wang C; Sun Z; Xiao J; Yan X; Chen Y; Yu J; Wu Y
Int J Nanomedicine; 2019; 14():8179-8193. PubMed ID: 31632026
[TBL] [Abstract][Full Text] [Related]
17. Enhanced mucosal immune responses against tetanus toxoid using novel delivery system comprised of chitosan-functionalized gold nanoparticles and botanical adjuvant: characterization, immunogenicity, and stability assessment.
Barhate G; Gautam M; Gairola S; Jadhav S; Pokharkar V
J Pharm Sci; 2014 Nov; 103(11):3448-3456. PubMed ID: 25219511
[TBL] [Abstract][Full Text] [Related]
18. Enhanced Immune Responses to Mucosa by Functionalized Chitosan-Based Composite Nanoparticles as a Vaccine Adjuvant for Intranasal Delivery.
Lin Y; Sun B; Jin Z; Zhao K
ACS Appl Mater Interfaces; 2022 Nov; 14(47):52691-52701. PubMed ID: 36382954
[TBL] [Abstract][Full Text] [Related]
19. Curdlan sulfate-
Zhang S; Huang S; Lu L; Song X; Li P; Wang F
Int J Nanomedicine; 2018; 13():2377-2394. PubMed ID: 29713168
[TBL] [Abstract][Full Text] [Related]
20. The enhancement of the immune response against S. equi antigens through the intranasal administration of poly-epsilon-caprolactone-based nanoparticles.
Florindo HF; Pandit S; Lacerda L; Gonçalves LM; Alpar HO; Almeida AJ
Biomaterials; 2009 Feb; 30(5):879-91. PubMed ID: 19027152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]